News at a glance.
Galenica continues to grow in 2024
Ad hoc announcement pursuant to Art. 53 LR, Tuesday, 11 March 2025
With sales up 4.7% in the 2024 financial year, the Galenica Group grew strongly and generated consolidated net sales of CHF 3,921.1 million. As a result, Galenica outperformed market growth and gained market share in all its main business areas. Adjusted1 EBIT increased by 10.3% to CHF 211.0 million. Excluding the one-off special factors in the previous year, the adjusted1 operating result (EBIT) would have increased by 4.9%. Adjusted1 net profit from continuing operations also increased by 13.4% to CHF 183.2 million. Due to this positive result, the Board of Directors will propose to the Annual General Meeting that the dividend be raised to CHF 2.30 per share, which corresponds to an increase of 4.5%.
News at a glance
Here you will find all ad hoc announcements, press releases and news about the Galenica network. Stay up to date and subscribe to our ad hoc announcements and press releases by e-mail.
Latest ad hoc announcements and press releases
All relevant news from the Galenica network in our ad hoc announcements and press releases.
Downloads for media
Images of various business activities from the Galenica network and the Galenica logo for journalistic use.
«We demonstrate how we create added value within the Galenica network; for our customers, employees, investors, partners and Switzerland’s healthcare system.»
Iris Müller, Head of Corporate Communications